Our Early Access Program provides an exclusive group of innovators with early access to our latest DNA breakthroughs. Program members can engage with our scientists and engineers in the early stages of product development to ensure that the needs of scientists and researchers using our products come first. In exchange for participation, members receive access to pre-commercial products with preferential pricing.
We currently have two programs available. Program members can have access to double-stranded DNA longer than 15,000 base pairs delivered in a plasmid or high-complexity sequences including plasmid replication origins, promoters, inverted terminal repeats (ITRs), and long terminal repeats (LTRs).
The problems our customers face with DNA supply cannot be resolved with a single product or innovation, so we are innovating in multiple areas of DNA synthesis,” says Marc Unger, Ph.D., Elegen CSO. “Our multidisciplinary team is eager to work closely with early access partners across industries to deliver DNA products that will enable them to accelerate more workflows without requiring them to invest their own effort, resources, and time.”READ MORE